Endocrinology Flashcards
Side effects of levothyroxine
Osteoporosis
Hyperthyroidism
AF
HbA1C Targets
Lifestyle +/- Metformin - 48
Lifestyle + hypoglycaemics - 53 (eg gliclazide)
T2DM Mx
Assess CVD risk (eg QRISK >10%)
- if no risk = metformin
- if risk = metformin first then + SGLT2 inhib (eg Dapagliflozin)
T2DM Mx when Metformin is contraindicated
No CVD risk = DPP‑4 inhibitor or pioglitazone or a sulfonylurea
CVD risk = SGLT2 inhib monotherapy (eg Dapagliflozin)
Obesity = add GLP-1 (Semaglutide)
CKD (eGFR <30) = DPP4-i (Linagliptin)
DVLA Diabetes rules
Can NOT drive unless:
- NOT been severe hypoglycaemia event in past 12 months
- 2 episodes hypoglycaemia in group 1 = no drive.
- 1 episode hypoglycaemia in group 2 = no drive
- has full hypoglycaemia awareness
- adequate blood sugar control (twice daily checks)
If Group 2 (HGV) - need to complete form for DVLA
All drivers must inform DVLA of diabetes on insulin
Blood pressure Mx for Diabetics
1st - ACEi or ARB
In Black patients choose ARB
Causes of raised prolactin
pregnancy
prolactinoma
physiological
polycystic ovarian syndrome
primary hypothyroidism
phenothiazines, metoclopramide, domperidone
Diabetes Diagnosis
If symptomatic:
- fasting Glucose >7.0
- random glucose >11.1 (or post glucose tolerance test)
HbA1C
- HbA1C >48 (6.5mmol) - check every 6 months once stable
- if asymptomatic test must be repeated
Prediabetes Ix
HbA1C 42-47 (6.0-6.4%) - checked once per year
Impaired fasting glucose
- fasting glucose 6.0-6.9
Impaired glucose tolerance
- fasting glucose <7.0
- and OGTT >7.8 but <11.1 (if above then diabetes)
Type 1 diabetes Mx
1st - basal–bolus using twice‑daily insulin detemir
2nd - basal-bolus using once-daily insulin determir or glargine
If BMI >25 add Metformin
Check HbA1c 3-6 monthly
HbA1c target <48
Thiazolidinediones (eg Pioglitazone) side effects
weight gain
liver impairment - monitor LFTs
fluid retention - contraindicated in CHF
fracture risk
bladder Ca
Metabolic syndrome Fx
> 3 of the following:
waist circumference: men > 102 cm, women > 88 cm
elevated triglycerides: > 1.7 mmol/L
reduced HDL: < 1.03 mmol/L in males, < 1.29 mmol/L in females
raised blood pressure: > 130/85 mmHg, or known HTN
raised fasting plasma glucose > 5.6 mmol/L, or known T2DM
Metabolic syndrome associated conditions
raised uric acid levels
non-alcoholic fatty liver disease
polycystic ovarian syndrome
Klinefelter’s syndrome biochemisty
Low Testosterone
High LH
Primary hyperparathyroidism biochemistry
High calcium
low phosphate
PTH can be high or normal
caused by parathyroid adenoma or hyperplasia